Abstract:(2E,4S)-4-(t-Butoxycarbonylamino)-5-[(3S)-2'-oxo-3'-pyrrolidinyl]-2-pentenoic acid ethyl ester(1) is a key intermediate widely used in drug candidate synthesis, such as the human rhinovious 3C protease inhibitor AG7088 and its related substances which are currently being developed for treatment of common cold, severe acute respiratory syndromes(SARS) and hand, foot, mouth disease(HFMD). Based on existing synthetic routes using L-glutamic acid as starting material, the optical purities of each intermediate product was rigorously examined, and the effects of reaction conditions on the optical purities of the products were studied in details. Meanwhile, racemic samples of each product were prepared from D, L-glutamic acids using the same procedures and used for comparison in high performance liquid chromatography(HPLC) analyses. Thus, new factors that could influence the optical purities of the final products were discovered, and methods for solving the problems were provided. The molecular structure of intermediate product (2S)-2-(t-butoxycarbonylamino)-3-[(3S)-2'-oxo-3'-pyrrolidinyl]propanol(5) was determined by the X-ray diffraction method, which provides direct evidence for the absolute configuration of these products.

Synthesis of 2-amino-9-(3-acetoxymethylbutyl)purine

Accelerated Effect on Mitsunobu Reaction Via Bis-N-tert-butoxycarbonylation Protection of 2-Amino-6-chloropurine and Its Application in a Novel Synthesis of Penciclovir

A New Method to Synthesize Famciclovir

Improved Synthetic Process for 3-Benzyloxy-4-n-butylaniline Hydrochloride

Synthesis of 3-Aminopyrrolidine and its N-alkylating Derivatives

Improved Synthesis of Penciclovir

Improved Synthesis of 2‐Chloro‐3‐amino‐4‐methylpyridine

Improved Synthesis of 1-[Hexahydrocyclopenta[c]pyrrol-2(1h)-yl]-3-(4-methylbenzenesulfonyl)ure A

Synthesis of 1- (2′-bromo-2′-deoxy-3′,5′-di-O-propionyl-β-D-ribosyl) thymidine

Development of Two Scalable Syntheses of 4-Amino-5-aminomethyl-2-methylpyrimidine: Key Intermediate for Vitamin B 1

Convenient Synthesis and Characterization of Novel 4-[2-ethoxy-5-(4-methyl-1-piperazinesulphonyl)benzamido]-3-isobutyl-1-methyl-1h-pyrazole-5-carboxamide: Key Precursor for Isobutyl Sildenafil

Synthesis of 1,3-(Diethoxymethyl)-5-n,n-dimethylamino-6-methyluracil

A Novel Method for Synthesizing 6-Chloro and 6-Methoxy Purinenucleoside

A new synthesis of the amine fragment: an important intermediate to the anti-HIV drug lenacapavir

Synthesis of cidofovir

Synthesis Of 2-(Substituted Amino)-4-N-Butyl-6-Methyl-5-Oxo-4,5-Dihydro-1,2,4-Triazolo[1,5-A]Pyrimid Ine Derivatives

Stereo Selective Synthesis and Absolute Configuration Determination of (2E,4s)-4-(t-butoxycarbonylamino)-5[(3s)-2 '-Oxo-3 '-Pyrrolidinyl]-2-pentenoic Acid Ethyl Ester

A New Synthesis of Enantiopure Amine Fragment: An Important Intermediate to the Anti-HIV Drug Lenacapavir

A New Route for the Synthesis of 4-Amino-5-fluoro-7-(2′-deoxy-2′-fluoro-2′-c-methyl-β-d- Ribofuranosyl)-1H-Pyrrolo[2,3-D]Pyrimidine

Microwave-Assisted Synthesis of the C-2,6 Derivatives of Purine and“Reversine”

Synthesis of 1-(Alkyl)-5-dimethylamino-6-phenethyluracils as Potent Nonnucleoside HIV-1 RT Inhibitors